Impatto del sistema di finanziamento a DRG sull’innovazione tecnologica in sanità. Il caso italiano

Journal title MECOSAN
Author/s Giuditta Callea, Aleksandra Torbica, Rosanna Tarricone
Publishing Year 2014 Issue 2014/89
Language Italian Pages 18 P. 31-48 File size 774 KB
DOI 10.3280/MESA2014-089003
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

In the last two decades the majority of Western countries adopted prospective payment schemes based on Diagnosis Related Groups (DRGs) for reimbursing hospital inpatient activity. Such payment schemes may play a relevant role in the adoption of new medical devices: each time a new devices comes to the market, decisions on its adoption rely on evaluations on the subsequent increase in costs and added therapeutic value. The goal of this research is (i) to identify, in a sample of Italian regions, the characteristics of regional reimbursement systems based on DRGs relevant for uptake and diffusion of new technologies, describing the updating mechanisms of DRG codes and rates that allow technological innovation to be formally incorporated in the reimbursement system and identifying alternative payment mechanisms developed with the aim of incentivize innovation; and (ii) to investigate the key-informants’ opinions and perceptions on the role of financing mechanisms based on DRG tariffs on the adoption and diffusion of medical devices in Italian hospitals.

Keywords: Technological innovation, diffusion, DRG

  • Rilevazione del gap tra DRG price e internal cost: implicazioni di case-mix accounting Cristiana Cattaneo, Gaia Bassani, in MANAGEMENT CONTROL 2/2017 pp.13
    DOI: 10.3280/MACO2017-002002
  • Applicazione della metodologia SMED per il miglioramento delle operations nelle sale operatorie. Il caso Azienda Ospedaliera Universitaria Senese Jacopo Guercini, Vincenzo Mezzatesta, Andrea Chiarini, Caterina Bianciardi, Lucia Bellandi, Sara Moi, Pasquale Biandolino, in MECOSAN 98/2016 pp.83
    DOI: 10.3280/MESA2016-098005

Giuditta Callea, Aleksandra Torbica, Rosanna Tarricone, Impatto del sistema di finanziamento a DRG sull’innovazione tecnologica in sanità. Il caso italiano in "MECOSAN" 89/2014, pp 31-48, DOI: 10.3280/MESA2014-089003